US · Healthcare · Healthcare Plans
EPS came in at 2.57 against a street estimate of 2.21 — a beat of 16.3%.
Analysts rate CVS Health Corp a strong buy (24 buy, 4 hold, 0 sell out of 28) with an average price target of $113.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 9.87% |
| Vanguard Capital Management, LLC | 6.48% |
| Capital World Investors | 6.05% |
| State Street Corp | 4.65% |
| Dodge & Cox | 4.06% |
| FMR Inc | 2.44% |
| JPMorgan Chase & Co | 2.31% |
| Geode Capital Management, LLC | 2.31% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-05-18 |
| Quarterly report · Q1 2026 | 2026-05-06 |
| Results announced · Q2 2026 | 2026-05-06 |
| Proxy statement · Q2 2026 | 2026-04-03 |
| Board / officer change · Q1 2026 | 2026-03-19 |
| Annual report FY2025 | 2026-02-10 |
| Results announced · Q1 2026 | 2026-02-10 |
| Quarterly report · Q3 2025 | 2025-10-29 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.67 / share ex-date Jul 23, 2026 · pay Aug 3, 2026 | 2026-07-23 |
| Dividend | $0.67 / share ex-date Apr 23, 2026 · pay May 4, 2026 | 2026-04-23 |
| Dividend | $0.67 / share ex-date Jan 22, 2026 · pay Feb 2, 2026 | 2026-01-22 |
| Dividend | $0.67 / share ex-date Oct 23, 2025 · pay Nov 3, 2025 | 2025-10-23 |
| Dividend | $0.67 / share ex-date Jul 22, 2025 · pay Aug 1, 2025 | 2025-07-22 |
| Announcement | Date |
|---|---|
| Updated 2025 full-year guidance and provided 2026 full-year guidance CVS Health issued an 8-K on December 9, 2025, disclosing information presented at its 2025 Investor Day. The filing references a press release (not included in this excerpt) that discussed t | 2025-12-09 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CVS Health Corp — free to start.
Google PlayApp StoreData updated 2026-08-05.